东方财富网 > 数据中心 > 研报大全 > 鹏博士 > 鹏博士-研报正文
  • 最新价 -
  • 涨跌 -
  • 涨跌幅 -
  • 换手 -
  • 总手 -
  • 金额 -

Costs were lower but so was the topline

www.eastmoney.com 2017年08月30日 00:00 James Wang,Peter Milliken

鹏博士(600804)

Current price not factoring in the significant slowdown

Dr. Peng continues to see pressure in its core broadband business withbroadband access revenue down 6% and its net adds slowing to ~100k in2Q17, the lowest rate in the past 4-5 years. Meanwhile, gross margin andARPU continue to decline and the business had to cut its opex by 10% in orderto deliver a more respectable 3% decline in net profit. Capex slowed sharply in1H17 and while this is a prudent move, future growth might also slow. Withthe shares trading on 33x FY17 EPS, this slower future growth does not seemto be factored in; retaining Sell.

Quarterly data show a deteriorating trend

2Q17 revenue declined 5% while gross profit fell 17%, a deterioration vs. thetrends seen in 1Q17. The company cut its 2Q sales and marketing expense by23% and management expense by 18% in order to deliver a flat profit but thisclearly had an impact on customer acquisition with net adds reducing to 100kin the quarter (vs. an average of 700k in the past 2 years). With Dr. Peng’sbroadband ARPU at RMB42/m, still significantly higher than China Mobile atRMB35/m, and given limited bundling offerings to differentiate its offerings,we think Dr. Peng’s business model continues to be challenged. Capex diddecline to RMB1.2bn in 1H17 from an average of RMB1.9bn in the previousfour halves, but the pace of its network rollout also slowed, adding only 2mhouseholds in coverage in the half.

Earnings changes

We have reduced our earnings forecasts in line with the lower-than-expected1H17 results. We have removed the equity raising, which increased the EPS.

Valuation and risks

We value Dr. Peng based on the mid-point of our peer-based valuation andDCF. Risks relate to market share, tax rate, regulation, and margins.

  • 行情
  • 资金流
  • 核心数据
  • 分时
  • 日K
  • 周K
  • 月K
鹏博士基本面数据
  • 总股本 14.32亿股
  • 流通股 14.32亿股
  • 每股收益 0.24元
  • 每股未分配利润 2.12元
  • 每股净资产 4.90元
  • 净资产收益率 4.82%
  • 净利润 34164.61万
  • 净利润增长率 -43.62%
鹏博士投资评级
一月内整体评级
三月内整体评级
统计时段 买入 增持 中性 减持 卖出 合计
一个月内000000
三个月内000000
半年内000000
一年内100001
鹏博士盈利预测
指标 2017A 2018E 2019E 2020E
每股收益(元) 0.54 0.00 0.00 0.00
净利润(亿元) 7.69 0.00 0.00 0.00
名称 涨跌幅 研报数 机构投资评级(近六个月)
买入 增持 中性 减持 卖出
中国联通 -1.11% 16 11 5 0 0 0
国脉科技 -1.44% 1 1 0 0 0 0
光环新网 -1.67% 24 16 8 0 0 0
鹏博士 -2.17% 0 0 0 0 0 0
二六三 -2.43% 0 0 0 0 0 0
机构一致看多个股
名称 研报 看多家数 最高
目标价
最低
目标价
现价
贵州茅台详细36861.00549.30671.00
中国国旅详细3386.8849.5658.90
北方华创详细2852.8937.6342.42
华鲁恒升详细2724.7212.1512.26
中炬高新详细2630.0022.0430.65
上汽集团详细2532.9723.2425.41
新宙邦详细2425.9421.5824.38
当升科技详细2330.4221.4327.60
广联达详细2230.1521.4023.28
三一重工详细2210.147.628.54
福能股份详细219.237.498.34
永辉超市详细217.997.018.18
瀚蓝环境详细2018.5412.0313.79
乐普医疗详细2037.7127.3020.35
宋城演艺详细2025.2419.3619.60

数据来源:东方财富Choice数据